One of the hallmarks of cancer is the existence of a high mutational load in driver genes, which is balanced by upregulation (downregulation) of DNA repair pathways, since almost complete DNA repair is required for mitosis. The prediction of cancer survival with gene expression has been investigated by many groups, however, results of a comprehensive re-evaluation of the original data adjusted by the PCNA metagene indicate that only a small proportion of genes are truly predictive of survival. However, little is known regarding the effect of the PCNA metagene on survival prediction specifically by DNA repair genes. We investigated prediction of overall survival (OS) in 18 cancers by using normalized RNA-Seq data for 126 DNA repair genes with expression available in TCGA. Transformations for normality and adjustments for age at diagnosis, stage, and PCNA metagene were performed for all DNA repair genes. We also analyzed genomic event rates (GER) for somatic mutations, deletions, and amplification in driver genes and DNA repair genes. After performing empirical p-value testing with use of randomly selected gene sets, it was observed that OS could be predicted significantly by sets of DNA repair genes for 61% (11/18) of the cancers. Pathway activation analysis indicates that in the presence of dysfunctional driver genes, the initial damage signaling and minor single-gene repair mechanisms may be abrogated, but with later pathway genes fully activated and intact. Neither PARP1 or PARP2 were significant predictors of survival for any of the 11 cancers. Results from cluster analysis of GERs indicates that the most opportunistic set of cancers warranting further study are AML, colorectal, and renal papillary, because of their lower GERs for mutations, deletions, and amplifications in DNA repair genes. However, the most opportunistic cancer to study is likely to be AML, since it showed the lowest GERs for mutations, deletions, and amplifications, suggesting that DNA repair pathway activation in AML is intact and unaltered genomically. In conclusion, our hypothesis-driven focus to target DNA repair gene expression adjusted for the PCNA metagene as a means of predicting OS in various cancers resulted in statistically significant sets of genes.
involved in replication and repair. In tumor cells, expression of PCNA is highly upregulated; however, PCNA-related activity is a normal process for DNA transcription in eukaryotes and therefore is not considered to play a central role in the selective genetic pressure associated with tumor development. Since PCNA is widely co-regulated with other genes in normal tissues, we developed workflow involving several functional transforms and regression models to "remove" the co-regulatory effect of PCNA on expression of DNA repair genes, and predicted overall cancer survival using DNA repair gene expression with and without removal of the PCNA effect. Other adjustments to survival prediction were employed, such as subject age at diagnosis and tumor stage. Random selection of gene sets was also employed for empirical p-value testing to determine the strength of the PCNA effect on DNA repair and overall survival adjustments. Since TCGA RNA-Seq data were used, we also characterized the frequency of deletions, amplifications, and somatic mutations in the DNA repair genes considered in order to observe which genomic events are the most frequent for the cancers evaluated.
data exist in the TCGA [5] . We also hypothesized that patterns of somatic mutations, 36 deletions, and amplifications in cancer-specific driver genes and the DNA repair genes 37 considered would provide new insight into the patterns of genomic alteration observed 38 in tumor cells. Results of the computational analyses were used for generating lists of 39 DNA repair genes, whose downregulation or upregulation therapeutically may 40 potentially confer prolonged survival of patients. As such, the focus of this project was 41 to identify patterns of DNA repair gene expression for recommending expression Base Excision Repair, BER. Base excision DNA repair (BER) corrects base 80 lesions generated by oxidative, alkylation, deamination, and 81 depurinatiation/depyrimidination damage. BER is initiated by DNA glycosylases, 82 which recognize and catalyze removal of damaged bases. Downstream enzymes carry 83 out strand incision, gap-filling, and ligation. BER involves two general pathways: 84 short-patch (SP-BER) and long-patch (LP-BER). BER genes employed in this study 85 included: APEX1, APEX2, APTX, FEN1, HUS1, LIG1, LIG3, MBD4, MPG, 86 MUTYH, NEIL1, NEIL2, NEIL3, NTH, OGG1, PARP1, PARP2, PCNA, PNKP, 87 POLB, POLD1, POLE, POLH, POLL, RECQL2, SMUG1, TDG, UNG, and XRCC1. 88 Non-homologous End-joining, NHEJ. Non-homologous end-joining (NHEJ) 89 repairs DSBs at all stages of the cell-cycle, bringing about the ligation of two 90 double-strand breaks (DSBs) without the need for sequence homology, and therefore 91 NHEJ is error-prone. NHEJ is referred to as " normalized expression values of the 131 PCNA-related genes [4] , and collapsed their 153 expression values down to median expression, which is termed the "PCNA metagene." 154 Next, the PCNA metagene (median) and expression values for all of the DNA repair 155 genes listed above were transformed into van der Waerden (VDW) scores. This Workflow for identifying the "best binarized PC" for a set of significant genes from univariate Kaplan-Meier analyses. A. van der Waerden (VDW) scores of log-transformed expression values for each DNA repair gene are regressed on the VDW scores for age at diagnosis, stage, and the PCNA metagene. B. The residual values from each linear fit (i.e., expression with the effect of age at diagnosis, stage, and PCNA metagene removed) are then binarized (0,1) and input as the univariate grouping value during Kaplan-Meier (KM) analysis of overall survival (OS). C. PCA with Varimax orthogonal rotation is performed on the correlation matrix of p significant binarized residual vectors. D. Each of the p principal component (PC) score vectors is binarized (0,1) and input into univariate KM analysis. E. The PC resulting in the greatest KM chi-squared value is selected as the "best binarized PC," and univariate Cox PH regression is then run on the best binarized PC to determine if positive (negative) PC score values are associated with prolonged (shortened) OS.
were used for residual generation was input into Cox proportional hazards (PH) having positive loading on the best binarized PC were beneficial to OS if upregulated, 182 whereas genes whose loadings were negative were considered hazardous, and would 183 need to be downregulated in order to be beneficial. Analogously, if the Cox PH hazard 184 ratio (HR) > 1, it meant that positive PC values were deleterious, and therefore genes 185 that loaded negatively on this PC would need to be upregulated to be beneficial, and 186 genes that loaded positively on this PC would need to be downregulated in order to be 187 beneficial to OS. Figure 1 illustrates the workflow employed, outlining the various 188 steps used for establishing the best binarized PC for each cancer, and whether positive 189 loadings on the best binarized PC prolonged or shortened OS.
190
Empirical P-value Tests of Survival Using Randomly Selected Genes. For 191 each cancer, the single best binarized PC that resulted in the greatest chi-squared 192 statistic during maximum likelihood KM analysis was considered to the be the 193 "observed" test statistic. Recall, this test statistic for the best binarized PC was 194 initially based on individual DNA repair genes whose adjusted gene expression 195 resulted in a significant KM test. Let the number of significant DNA repair genes for a 196 best binarized PC be p. We used B = 1, 000 iterations for empirical p-value testing. 
where χ 2 1 is the "observed" 1 d.f. chi-squared test statistic from ML-based KM 204 analysis based on the best binarized PC, and χ illustrates how the correlation matrix of p genes with significant KM analysis were 208 employed to obtain the best binarized PC for predicting OS.
209
Genomic Event Rates (GERs 200 0.0062 0.0018 0.0157 0.0062 0.0120 0.0020 0.0130 0.0130 Bladder 413 0.0000 0.0000 0.0000 0.0001 0.0190 0.0180 0.0160 0.0360 Low Grade Giomas 530 0.0000 0.0000 0.0000 0.0000 0.5740 0.2760 0.3880 0.3520 GBM 604 0.0090 0.0005 l0.0231 0.0008 0.0270 0.0040 0.1600 0.0030 Head & Neck 530 0.0005 0.0009 0.0006 0.0008 0.0150 0.1370 0.1120 0.0110 Sarcoma 265 0.0011 0.0032 0.0008 0.0001 0.1200 0.0520 0.0120 0.0150 A-Expression adjusted for age at diagnosis. P-Expression adjusted for PCNA metagene expression. A,P-Expression adjusted for age at diagnosis and PCNA metagene expression. N-No adjustment to expression. a -KM logrank test of binarized principal component scores from correlation matrix of DNA repair genes with significant logrank tests. b -P-values based on number of times KM logrank test χ 2 (b) based on randomly selected genes exceeded χ 2 (1) based on non-random genes. mostly downregulated due to downregulation of HR23B, TFIH, XPC, and XPG. We 277 also noted that the single gene repair mechanism via MGMT was also downregulated, 278 which would increase SSBs and their conversion to DSBs at replication forks [13] . 279 Another observation was that neither PARP1 or PARP2 were listed in any of the lists 280 of significant genes, which may indicate co-regulation with PCNA, whose effect on 281 expression of other DNA repair genes was removed. Genomic event rates. Hierarchical cluster analysis results of genomic event rates (GER, per tumor-gene) for somatic mutations ("mut"), deletions ("del"), and amplifications ("amp") in driver genes ("dr") and the 8 groups of DNA repair genes (DRR, BER, NHEJ, MMR, TLS, DDS, HRR, NER). Euclidean distance used as the distance function, with unweighted pair group method with arithmetic mean (UPGMA) as the agglomeration method.
282
Results of cluster analysis of the GER for various cancers is shown in Figure 2 . A 283 total of 4 clusters of cancers were discernible in the data. In spite of all the cancers 284 exhibiting high GERs for driver mutations, cancers in cluster 1 portrayed strong 285 upregulation of genomic amplification in DNA repair genes, while cancers in cluster 2 286 reveal downregulation of amplification, deletion, and mutation in DNA genes.
287
Melanoma and ovarian cancer clustered furthest away from the previously described 288 clusters, mostly because of the unique patterns among GERs which emerged.
289
Regarding driver genes, both melanoma and ovarian cancer exhibited greater rates of 290 amplifications, but had lower rates of deletions. Additionally, while melanoma 291 revealed increased rates of mutations in DNA repair genes and decreased rates of 292 deletions in DNA repairs genes, ovarian cancer showed the opposite pattern, with 293 lower rates of mutations in DNA repair genes and greater rates of deletions in DNA 294 repair genes. Table 4 lists qualitative patterns which emerged from the cluster analysis 295 of GERs shown in Figure 2 .
296 Table 4 . Qualitative patterns of genomic event rates (GER) per gene-tumor for each cluster identified during hierarchical cluster analysis (from Figure 2) . Opportunistic cancers for further study in cluster 2 are AML, Colorectal, and Renal Papillary. Tables 1 and 2 were extracted from Figures S1-S36. 301 
DISCUSSION

302
Cancer is a multifactorial disease which depends on a constellation of factors involving 303 genomic instability, selective genetic pressure from somatic mutations and 304 polymorphisms, and gene-environment interactions. Two important hallmarks of 305 cancer are the persistent high level of somatic mutations in driver genes and 306 genome-wide error-prone transcriptional coding by polymerases. Together, these DNA repair mechanisms with a high level of fidelity. As the costs of nextgen DNA 310 sequencing and RNA-Seq analysis decrease, there will continue to be new information 311 available regarding the balance between mutational load and DNA repair.
312
Our approach employed two levels of statistical testing, one that merely involved 313 straightforward ML estimation and another based on random gene selection, which 314 resulted in empirical p-values. The ML-based survival prediction with adjusted DNA 315 repair gene expression was significant for most of the cancers; however, survival 316 prediction based on empirical p-values was significant for fewer cancers. It is now 317 known that identification of sets of genes from genome-wide annotation lists will result 318 in false positives that are associated with the PCNA metagene. Our focus was to 319 specifically target DNA repair gene expression, remove the effect of the PCNA 320 metagene, age at diagnosis, and stage, to determine if significant lists can be obtained. 321 Not surprisingly, after the adjustments, many of the cancers revealed DNA repair 322 genes which significantly predicted OS.
323
Pathway analysis results indicate a pattern suggestive of downregulation of primary 324 damage signaling kinase (ATM ) and initial BER pathway components (APEX1 and 325 OGG1 ), and when combined with increased pathogenic somatic mutations in driver 326 genes (e.g., TP53 ), our results may indicate that initial damage signaling mechanisms 327 are abrogated, but the full compliment of DNA repair is intact. There was also an 328 observation that a single-gene repair mechanism was abrogated, which may be 329 suggestive that minor repair mechanisms are also abrogated. 330 We also assessed GERs of the various cancers, and confirmed that all of the cancers 331 had high somatic mutation rates in driver genes. There were also two main clusters of 332 cancers identified, which portrayed either high levels of amplification in DNA repair 333 genes or low GERs for mutations, deletions, and amplification in DNA repair genes.
334
The latter group of cancers including AML, colorectal, GBM, low grade gliomas, and 335 renal papillary (cluster 2 in Table 4 ), may be more opportunistic for investigating 336 further because the low levels of mutations, deletions, and amplification in DNA repair 337 genes would suggest that the suppressed and activated DNA repair pathways in these 338 cancers are intact and unaltered genomically. When considering results of empirical 339 p-value testing, this list of cancers becomes reduced to AML, colorectal, and renal 340 papillary, since OS for GBM and low grade gliomas could not be predicted 341 significantly using random gene tests.
342
Implementing our recommendations for therapy would require a way to actively 343 suppress or activate various DNA repair pathways, depending on the pattern of repair 344 observed within certain cancers. RNA interference (RNAi) has recently proven to be a 345 valid mechanism for engaging RNAi pathways for the purpose of targeted therapy for 346 cancer patients [14] . Recently, it has been shown that silencing RNA (siRNA) 347 administered systemically to a human can produce a specific gene inhibition 348 (reduction in mRNA and protein) by an RNAi mechanism of action [15] . The as well as randomized control trials for establishing safety and evaluating efficacy. 362 We did not comparatively assess numerous techniques for their computational 363 efficiency, scalability, or differences in OS survival prediction. We also did not evaluate 364 differences between using progression free survival (PFS) vs. OS, or bootstrapping 365 effects on results. An advantage of using OS instead of PFS with TCGA data, is that 366 there are fewer late stage (i.e., stage 4) cancers in TCGA data. In fact, prostate cancer 367 tumors in TCGA have much more data regarding PFS than OS. As such, OS will likely 368 be more informative for more virulent tumors. The work presented here suggests that 369 investigation of the effects of PNCA metagene on DNA repair gene expression and OS 370 survival prediction can establish new leads for future research on cancer therapeutics.
371
There are several challenging issues surrounding OS prediction using TCGA data.
372
First, there is the problem of unknown upstream effects of germline polymorphisms 373 and DNA repair deficiencies which may result in a variety of unknown influences.
374
Second, the difficulty presented by cellular niching and high levels of clonal 375 heterogeneity in tumors presents a challenge for fully unraveling the associations 376 observed in this study. The TCGA data used are not based on single-cell RNA-Seq 377 analysis, which would be helpful for elucidating heterogeneity effects; however, the 378 large variation in genotypes would exacerbate the present uncertainties surrounding 379 our attempt to portray the role of DNA repair genes in cancer survival. We also did 380 not consider DNA microsatellite instability, methylation status, or chromosome 381 aberrations, which would overlay more complexity on the models developed.
382
In conclusion, our hypothesis-driven focus to target DNA repair gene expression 383 adjusted for the PCNA metagene as a means of predicting OS in various cancers 384 resulted in statistically significant sets of DNA repair genes. We also identified that 385 AML, colorectal, and renal papillary cancers may be more opportunistic for future 386 knowledge discovery because of the low rates of mutations, deletions, and 387 amplification in DNA repair genes which predict OS in these cancers. The most 388 opportunistic cancer appears to be AML, since it harbors the lowest rates of somatic 389 mutations, deletions, and amplifications in DNA repair genes. 
